Cargando…
Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations
Oral inhalation of drugs is the classic therapy of obstructive lung diseases. In contrast to the oral route, the link between in vitro and in vivo findings is less well defined and predictive models and parameters for in vitro-in vivo correlations are missing. Frequently used in vitro models and pro...
Autor principal: | Fröhlich, Eleonore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680885/ https://www.ncbi.nlm.nih.gov/pubmed/31284402 http://dx.doi.org/10.3390/pharmaceutics11070316 |
Ejemplares similares
-
Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening
por: Fröhlich, Eleonore
Publicado: (2017) -
Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, ex Vivo, in Vitro, and in Silico Studies
por: Fröhlich, Eleonore, et al.
Publicado: (2014) -
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
por: Fröhlich, Eleonore
Publicado: (2021) -
In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release Formulations
por: Shi, Changzhi, et al.
Publicado: (2023) -
Editorial: Advances in orally inhaled and nasal drug products (OINDPs)
por: Mehta, Piyush Pradeep, et al.
Publicado: (2023)